NUTX Nutex Health Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: NUTX

Price (delayed)

$135

Market cap

$928.98M

P/E Ratio

9.99

Dividend/share

N/A

EPS

$13.52

Enterprise value

$1.07B

?
Relative Growth: Rel. Growth: 76
Relative Strength: Rel. Strength: 69
Relative Valuation: Rel. Valuation: 84
Relative Profitability: Rel. Profitability: 91

nutex health is a consortium of licensed 24/7 free standing emergency centers. our philosophy is simple: bring concierge level, high quality emergency care to the local community. we build the ...

Highlights
NUTX's equity has soared by 96% YoY and by 5% from the previous quarter
The revenue is up by 41% year-on-year
The company's quick ratio has surged by 53% YoY but it fell by 7% QoQ
Nutex Health's gross profit has increased by 37% YoY but it has decreased by 6% QoQ
The company's gross margin fell by 6% QoQ and by 2.7% YoY
NUTX's P/E is 3.4% above its last 4 quarters average of 9.5
Sector: Healthcare
Industry: Health Information Services
Peers: SEM

Key stats

What are the main financial stats of NUTX

NUTX stock price

How has the Nutex Health stock price performed over time
Intraday
1.63%
1 week
3.38%
1 month
-8.27%
1 year
-0.46%
YTD
-17.99%
QTD
42.05%

Financial performance

How have Nutex Health's revenue and profit performed over time
Revenue
$879.95M
Gross profit
$417.67M
Operating income
$276.21M
Net income
$96.38M
Gross margin
47.5%
Net margin
11%
The revenue is up by 41% year-on-year
Nutex Health's gross profit has increased by 37% YoY but it has decreased by 6% QoQ
The net margin has grown by 36% from the previous quarter but it has contracted by 7% YoY
The net income is up by 36% since the previous quarter and by 31% year-on-year

Price vs fundamentals

How does NUTX's price correlate with its fundamentals

Growth

What is Nutex Health's growth rate over time

Valuation

What is Nutex Health stock price valuation
NUTX P/E details
P/E
9.99
P/B
2.72
P/S
1.07
EV/EBIT
6.1
EV/EBITDA
5.45
EV/Sales
1.21
NUTX's EPS is up by 21% QoQ but it is down by 4% YoY
NUTX's P/E is 3.4% above its last 4 quarters average of 9.5
NUTX's equity has soared by 96% YoY and by 5% from the previous quarter
The P/B is 24% below the 5-year quarterly average of 3.5 but 2.7% above the last 4 quarters average of 2.6
The revenue is up by 41% year-on-year
The stock's price to sales (P/S) is 38% less than its 5-year quarterly average of 1.7 but 17% more than its last 4 quarters average of 0.9

Efficiency

How efficient is Nutex Health business performance
Nutex Health's return on equity has shrunk by 54% YoY but it has increased by 18% QoQ
NUTX's ROA is up by 30% from the previous quarter but it is down by 19% YoY
NUTX's ROS is up by 11% QoQ but it is down by 4.8% YoY
Nutex Health's ROIC has increased by 8% from the previous quarter and by 2.6% YoY

Dividends

What is NUTX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NUTX.

Financial health

How did Nutex Health financials performed over time
The total assets is 86% greater than the total liabilities
The company's quick ratio has surged by 53% YoY but it fell by 7% QoQ
The current ratio has soared by 53% YoY but it has contracted by 8% from the previous quarter
NUTX's equity has soared by 96% YoY and by 5% from the previous quarter
The debt to equity has contracted by 48% YoY and by 6% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.